CVS Health boosts guidance
Digest more
CVS raises profit forecast
Digest more
CVS Health’s 22.1% return over the past six months has outpaced the S&P 500 by 8.7%, and its stock price has climbed to ...
Discover why CVS Health Corporation is a top S&P 500 performer in 2025. See bullish forecasts, strong growth, and a new price ...
CVS Health’s Aetna health insurance unit said it will “integrate pharmacy prescriptions and medical procedures into a single ...
As part of the settlement, CVS admitted and accepted responsibility for certain conduct alleged by the government, including ...
CVS Health Corporation is rated a Buy with a strong turnaround driving industry-leading results. Learn more about CVS stock ...
CVS is bringing together its disparate businesses onto one platform, and giving its rivals the option to add their products ...
Fintel reports that on December 10, 2025, Mizuho maintained coverage of CVS Health (NYSE:CVS) with a Outperform ...
CVS Health’s (NYSE: CVS) latest results affirm several points: their sales and adjusted profits remain stable, and they are adjusting their forecasts upward. Nonetheless, the quality of their ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback